CJC-1295 No DAC (Modified GRF) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.
Researched Benefits:
- Potent GHRH receptor agonist for investigating selective somatotroph-mediated growth hormone signaling
- Supports analysis of pulsatile growth hormone secretion in various cellular models
- Enables research on cAMP-dependent protein kinase A activation and downstream transcription
- Useful for evaluating the hypothalamic-pituitary-somatotropic axis without long-term albumin conjugation
Description
CJC-1295 NO DAC 5mg is a research peptide widely studied for its potential to enhance growth hormone secretion without the extended half-life associated with DAC (Drug Affinity Complex). By stimulating the release of GH and IGF-1, it plays a key role in muscle growth, fat metabolism, and recovery research. Our CJC-1295 NO DAC is synthesized with the highest purity standards, ensuring reliability for scientific investigations.
Key Features:
- High-purity peptide, rigorously tested for consistency and quality.
- Designed for researchers studying GH and IGF-1 modulation.
- Supplied in lyophilized form for stability and longevity under proper storage conditions.
Applications:
- Investigating the effects of GH secretion on muscle growth and fat metabolism.
- Exploring the potential impact on cellular repair and recovery.
- Studying its role in age-related GH decline and anti-aging research.
- Assessing its use in performance enhancement and tissue regeneration studies.
Specifications and Documentation
CJC-1295 NO DAC 5mg is a powerful tool for research into growth hormone modulation, metabolism, and recovery, making it an essential component in advanced scientific studies.
